Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses

JAMA Neurology
Kerstin HellwigAnnette Langer-Gould

Abstract

Women with multiple sclerosis (MS) experience an elevated risk of relapse after giving birth. The effect of exclusive breastfeeding on postpartum risk of MS relapse is unclear. To determine the effect of exclusive breastfeeding on postpartum risk of MS relapse and to investigate the effect of introducing supplemental feedings on that risk. Data on 201 pregnant women with relapsing-remitting MS were collected prospectively from January 1, 2008, to June 30, 2012, with 1 year follow-up post partum in the nationwide German MS and pregnancy registry. The effect of the intention to breastfeed exclusively (no regular replacement of breastfeeding meals with supplemental feedings) for at least 2 months compared with nonexclusive breastfeeding (partial or no breastfeeding) on the first postpartum MS relapse, using Cox proportional hazards regression model adjusted for age and disease activity, before and during pregnancy was analyzed. Data analysis was performed from August 30, 2013, to May 25, 2015. Exclusive breastfeeding defined as at least 2 months of breastfeeding without regular replacement of any meal by supplemental feeding. First postpartum MS relapse. Of 201 women, 120 (59.7%) intended to breastfeed exclusively for at least 2 m...Continue Reading

Citations

Feb 13, 2016·Revue neurologique·G MpandzouM Yahyaoui
Aug 10, 2016·Seminars in Immunopathology·Stefan M Gold, Rhonda R Voskuhl
Nov 11, 2016·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Trygve Holmøy, Øivind Torkildsen
Mar 24, 2017·Expert Opinion on Drug Safety·Jan ThöneKerstin Hellwig
Jun 27, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Cavit BozMurat Emrah Mavis
Feb 28, 2018·Frontiers in Immunology·Vânia Vieira BorbaYehuda Shoenfeld
Aug 3, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Rhonda Voskuhl, Callene Momtazee
Jan 9, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Riley Bove, Wendy Gilmore
Sep 18, 2018·Immunology·María C Ysrraelit, Jorge Correale
Feb 23, 2019·Multiple Sclerosis : Clinical and Laboratory Research·Emilio Portaccio, Maria Pia Amato
Mar 29, 2019·The Medical Journal of Australia·Anneke Van Der WaltVilija Jokubaitis
Jun 5, 2019·Continuum : Lifelong Learning in Neurology·Annette M Langer-Gould
Jul 14, 2017·Neurology·Annette Langer-GouldAnny Xiang
Nov 3, 2017·Neurology·Eric C KlawiterBrian Weinshenker
Feb 14, 2018·Neurology·Emilio PortaccioUNKNOWN MS Study Group of the Italian Neurological Society
Apr 15, 2020·Neurology·Annette Langer-GouldStephen K Van Den Eeden
Jun 11, 2020·Expert Opinion on Pharmacotherapy·Johanna B Andersen, Melinda Magyari
Mar 27, 2020·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Natalie V ScimeKatie H Chaput
May 26, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Diana FerraroPatrizia Sola
Jun 16, 2017·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·D S KasatkinA S Shytova
Aug 5, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Maria Pia AmatoGiancarlo Comi
Jan 13, 2019·Clinical Rheumatology·Vânia Vieira Borba, Yehuda Shoenfeld
May 22, 2020·Neurology. Neuroimmunology and Neuroinflammation·Andrea Ines CipleaKerstin Hellwig
May 3, 2020·Neurology. Neuroimmunology and Neuroinflammation·Jessica B SmithAnnette Langer-Gould
Sep 13, 2020·Neurology. Neuroimmunology and Neuroinflammation·Maria HoutchensRohit Bakshi
Dec 7, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Gabriel BstehThomas Berger
Apr 24, 2019·Biomedicines·Kelly Tisovic, Lilyana Amezcua
Jul 14, 2020·Therapeutic Advances in Neurological Disorders·Kristen M KryskoKerstin Hellwig
Jan 13, 2017·Multiple Sclerosis International·Raed AlroughaniSaeed Bohlega
Aug 9, 2019·Annals of Clinical and Translational Neurology·Emmanuelle WaubantAnnette Langer-Gould
Nov 19, 2019·Archives of public health = Archives belges de santé publique·Raha AfsharianiZahra Zamanian
Nov 16, 2020·Frontiers in Neuroendocrinology·Maddalena Sparaco, Simona Bonavita
Dec 16, 2020·Multiple Sclerosis and Related Disorders·Bernardita SolerClaudia Cárcamo
Aug 2, 2020·Revue neurologique·S VukusicC Lebrun-Frenay
Apr 3, 2021·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Lubna AlmouzainFiona Hamilton
Apr 6, 2021·Current Treatment Options in Neurology·Kristen M KryskoKerstin Hellwig
Apr 17, 2021·Revista brasileira de ginecologia e obstetrícia : revista da Federação Brasileira das Sociedades de Ginecologia e Obstetrícia·Gabrielle Maria Carvalho de BarrosSabina Bastos Maia
Feb 21, 2021·Neurology. Neuroimmunology and Neuroinflammation·Annika AndersonRiley Bove

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.